Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-099884
Filing Date
2025-07-30
Accepted
2025-07-30 07:45:46
Documents
51
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-20250630.htm   iXBRL 10-Q 1660953
2 EX-31.1 wve-ex31_1.htm EX-31.1 17119
3 EX-31.2 wve-ex31_2.htm EX-31.2 17297
4 EX-32 wve-ex32.htm EX-32 13038
5 GRAPHIC img58267627_0.jpg GRAPHIC 292579
6 GRAPHIC img58267627_1.jpg GRAPHIC 205871
  Complete submission text file 0000950170-25-099884.txt   6496401

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT wve-20250630.xsd EX-101.SCH 810112
54 EXTRACTED XBRL INSTANCE DOCUMENT wve-20250630_htm.xml XML 554930
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 251163991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)